Results 21 to 30 of about 9,499 (196)
Complement System and C4d expression in cases of Membranous nephropathy
Introduction: Membranous nephropathy (MN) is one of the major causes of nephrotic syndrome. The complement system plays a key role in the pathophysiology of MN.
Fabiano Bichuette Custódio +4 more
doaj +2 more sources
Glomerular C4d deposition in proliferative glomerular diseases
Introduction: The aim of this study was to evaluate the immunohistochemical expression of C4d in native renal biopsies of proliferative glomerular diseases, complement pathways in these diseases, and assess the relationship of C4d with histological and ...
Sarojini Raman +4 more
doaj +3 more sources
Premature, accelerated onset of atherothrombotic disease is prevalent in patients with systemic lupus erythematosus (SLE). Most, if not all, atherothrombotic diseases are likely to involve platelets and complement.
Chau-Ching Liu +4 more
doaj +2 more sources
C4d Deposition in Cardiac Allografts Correlates With Alloantibody
The presence of C4d along the peritubular capillaries in kidney allografts correlates with the presence of anti-donor serum alloantibodies. We applied C4d staining to cardiac allograft and non-allograft biopsies to determine if C4d staining in heart ...
Disalvo, Thomas +9 more
core +3 more sources
C4d as a Practical Marker for Cutaneous Amyloidosis
Cutaneous amyloidosis (CA) is defined by the accumulation of amyloid in the dermis; it might be primary or secondary. The diagnosis is based on histopathological findings with the demonstration of amyloid deposits, confirmed by Congo red stain under the ...
Sait Şen +10 more
core +3 more sources
I was a late comer to C4D. Only when I started the Master\u27s in communication for development at Malmö in 2005 did I discover there was a world of theory and people and background in this area that I had been working on incognito most of my working ...
Davies, Jackie
core +4 more sources
An Approach to Antibody-Mediated Rejection in Pediatric Liver Transplantation. [PDF]
ABSTRACT Antibody‐mediated rejection (AMR) is an important but infrequent cause of pediatric liver allograft injury. There is a lack of standardized guidance, and treatment approaches vary across institutions. A writing group from the Society of Pediatric Liver Transplantation conducted a comprehensive review of the published literature and collected ...
Jaramillo C +8 more
europepmc +2 more sources
Angiotensin Type 1 Receptor Antibody Positivity in a Pediatric Liver Transplant Patient With Antibody-Mediated Rejection: A Case Report. [PDF]
ABSTRACT Background Antibody‐mediated rejection (AMR) in pediatric liver transplantation (LT) is uncommon and poorly understood. While human leukocyte antigen (HLA) antibodies are usually implicated in AMR, non‐HLA antibodies have also been reported. Methods We describe a 7‐year‐old female with non‐HLA AMR in the setting of positive angiotensin type 1 ...
Su T +8 more
europepmc +2 more sources
Non-HLA Antibody-Associated Hyperacute Allograft Rejection Following Lung Transplantation. [PDF]
ABSTRACT Background Pediatric‐onset pulmonary hypertension (PH) is a rare, progressive pulmonary vascular disease associated with high mortality. In cases unresponsive to pharmacological therapy with a severe cardiorespiratory phenotype, lung transplantation (LT) remains the final treatment option. Although LT for pediatric PH is considered a procedure
Karolak JA +11 more
europepmc +2 more sources
Glomerular plasmalemma vesicle-associated protein-1 as an endothelial remodelling marker complementing C4d in chronic active antibody-mediated rejection. [PDF]
Glomerular plasmalemma vesicle‐associated protein‐1 (PV‐1/PLVAP) identifies dynamic endothelial remodelling in chronic active antibody‐mediated rejection (caABMR), complementing glomerular C4d, which reflects a static footprint of complement activation. Combined assessment of PV‐1 and C4d captures complementary dimensions of microvascular pathology and
Igarashi Y +7 more
europepmc +2 more sources

